Journey Medical Corp. (DERM)
3.30
-0.25
(-7.04%)
USD |
NASDAQ |
Nov 20, 15:51
Journey Medical Total Assets (Quarterly) : 103.85M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 103.85M |
| June 30, 2026 | 98.36M |
| March 31, 2026 | 91.53M |
| December 31, 2025 | 94.59M |
| September 30, 2025 | 85.19M |
| June 30, 2025 | 81.16M |
| March 31, 2025 | 84.96M |
| December 31, 2024 | 80.24M |
| September 30, 2024 | 64.04M |
| June 30, 2024 | 65.19M |
| March 31, 2024 | 66.57M |
| December 31, 2023 | 76.85M |
| Date | Value |
|---|---|
| September 30, 2023 | 65.92M |
| June 30, 2023 | 69.75M |
| March 31, 2023 | 95.85M |
| December 31, 2022 | 105.16M |
| September 30, 2022 | 108.14M |
| June 30, 2022 | 113.50M |
| March 31, 2022 | 120.90M |
| December 31, 2021 | 97.28M |
| September 30, 2021 | 89.06M |
| June 30, 2021 | 72.72M |
| March 31, 2021 | |
| December 31, 2020 | 51.91M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Talphera, Inc. | 23.57M |
| Fortress Biotech, Inc. | 280.22M |
| Relmada Therapeutics, Inc. | 205.30M |
| Turn Therapeutics, Inc. | 16.35M |
| ANI Pharmaceuticals, Inc. | 1.568B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 71.60M |
| Shareholders Equity (Quarterly) | 32.25M |
| Debt to Equity Ratio | 0.7945 |
| Current Ratio | 1.481 |
| Net Debt Paydown Yield | -0.04% |